Dr. Noah Alexander Levit, MD, PhD

Dr. Levit practices at Connecticut Skinhealth in Shelton, Connecticut.

Dr. Levit's NPI, 1710334420, was assigned on May 23, 2016. Dr. Levit graduated from State University of New York at Stony Brook, School of Medicine in 2016. Dr. Levit holds Connecticut license 65128.

Dr. Levit's primary practice is Connecticut Skinhealth, at 4 Corporate Dr, Shelton, CT 06484 in Greater Bridgeport County. The practice phone is (203) 538-5685.

Dr. Levit's primary practice is Connecticut Skinhealth in Shelton, Connecticut. The medical group on file is Dermatology Physicians of Connecticut. Dmand AI also links Dr. Levit to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Levit practices. Vendor and product names are available with a free account.

Dermatopathology is Dr. Levit's primary specialty in the NPI Registry, under taxonomy code 207ND0900X. Dr. Levit is licensed in Connecticut.

CMS data shows 2,119 Medicare services from Dr. Levit across 11 procedure codes in 2024, for 515 Medicare patients. Medicare paid $82,926 for them. Every service was in an office.

CMS counts 515 Medicare patients who saw Dr. Levit in 2024. The largest group is 65 to 74, with 217 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Levit's median patient age at 54, with 40% women.

In 2024, Dr. Levit wrote 1,446 Medicare Part D claims for 542 patients. 89% of them were for generic drugs. CMS names the drug for 1,282 of them, across 28 drugs with 11 or more claims each, at $275,522 in total drug cost. In 2023, CMS named 866 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Levit for performance year 2024, reported as part of a group. Dr. Levit accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 452 procedures of removal of skin lesions by Dr. Levit, more than 86% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Dr. Levit to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Eczema and Dermatitis, Atopic. Regeneron Pharmaceuticals sponsors the most, 2. Open Payments lists research payments to Dr. Levit that name 3 trials.

CMS Open Payments shows 1,120 general payments to Dr. Levit from 24 drug and device companies from 2022 to 2025. Speaker and faculty fees make up the largest share, 62% of the total. Eli Lilly and Company paid the most, $142,319. It also lists 27 research payments totaling $24,433 from 2023 to 2025, naming 3 clinical trials.

Dr. Levit graduated from State University of New York at Stony Brook, School of Medicine in 2016.